268 related articles for article (PubMed ID: 16478733)
1. Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis.
Jiang N; Wang X; Jhanwar-Uniyal M; Darzynkiewicz Z; Dai W
J Biol Chem; 2006 Apr; 281(15):10577-82. PubMed ID: 16478733
[TBL] [Abstract][Full Text] [Related]
2. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.
Conn CW; Hennigan RF; Dai W; Sanchez Y; Stambrook PJ
Cancer Res; 2000 Dec; 60(24):6826-31. PubMed ID: 11156373
[TBL] [Abstract][Full Text] [Related]
3. The role of Polo-like kinase 1 in the inhibition of centrosome separation after ionizing radiation.
Zhang W; Fletcher L; Muschel RJ
J Biol Chem; 2005 Dec; 280(52):42994-9. PubMed ID: 16157594
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus.
Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Menendez JA
Cell Cycle; 2011 Apr; 10(8):1295-302. PubMed ID: 21474997
[TBL] [Abstract][Full Text] [Related]
5. Screening of domain-specific target proteins of polo-like kinase 1: construction and application of centrosome/kinetochore-specific targeting peptide.
Ji JH; Jang YJ
J Biochem Mol Biol; 2006 Nov; 39(6):709-16. PubMed ID: 17129406
[TBL] [Abstract][Full Text] [Related]
6. Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1.
Liu X; Zhou T; Kuriyama R; Erikson RL
J Cell Sci; 2004 Jul; 117(Pt 15):3233-46. PubMed ID: 15199097
[TBL] [Abstract][Full Text] [Related]
7. Requirement of hCenexin for proper mitotic functions of polo-like kinase 1 at the centrosomes.
Soung NK; Kang YH; Kim K; Kamijo K; Yoon H; Seong YS; Kuo YL; Miki T; Kim SR; Kuriyama R; Giam CZ; Ahn CH; Lee KS
Mol Cell Biol; 2006 Nov; 26(22):8316-35. PubMed ID: 16966375
[TBL] [Abstract][Full Text] [Related]
8. Functional dynamics of Polo-like kinase 1 at the centrosome.
Kishi K; van Vugt MA; Okamoto K; Hayashi Y; Yaffe MB
Mol Cell Biol; 2009 Jun; 29(11):3134-50. PubMed ID: 19307309
[TBL] [Abstract][Full Text] [Related]
9. Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis.
van Vugt MA; van de Weerdt BC; Vader G; Janssen H; Calafat J; Klompmaker R; Wolthuis RM; Medema RH
J Biol Chem; 2004 Aug; 279(35):36841-54. PubMed ID: 15210710
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1 regulates RhoA during cytokinesis exit in human cells.
Dai BN; Yang Y; Chau Z; Jhanwar-Uniyal M
Cell Prolif; 2007 Aug; 40(4):550-7. PubMed ID: 17635521
[TBL] [Abstract][Full Text] [Related]
11. Polo-box motif targets a centrosome regulator, RanGTPase.
Jang YJ; Ji JH; Ahn JH; Hoe KL; Won M; Im DS; Chae SK; Song S; Yoo HS
Biochem Biophys Res Commun; 2004 Dec; 325(1):257-64. PubMed ID: 15522227
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity.
Wang Q; Xie S; Chen J; Fukasawa K; Naik U; Traganos F; Darzynkiewicz Z; Jhanwar-Uniyal M; Dai W
Mol Cell Biol; 2002 May; 22(10):3450-9. PubMed ID: 11971976
[TBL] [Abstract][Full Text] [Related]
13. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
14. Identification of a nuclear localization signal in the polo box domain of Plk1.
Lee MS; Huang YH; Huang SP; Lin RI; Wu SF; Li C
Biochim Biophys Acta; 2009 Oct; 1793(10):1571-8. PubMed ID: 19631697
[TBL] [Abstract][Full Text] [Related]
15. DITMD-induced mitotic defects and apoptosis in tumor cells by blocking the polo-box domain-dependent functions of polo-like kinase 1.
Kim KU; Lee JH; Lee MY; Chae CH; Lee JH; Lee BH; Oh KS
Eur J Pharmacol; 2019 Mar; 847():113-122. PubMed ID: 30689997
[TBL] [Abstract][Full Text] [Related]
16. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
Shan HM; Shi Y; Quan J
ChemMedChem; 2015 Jan; 10(1):158-63. PubMed ID: 25196850
[TBL] [Abstract][Full Text] [Related]
17. Functional studies on the role of the C-terminal domain of mammalian polo-like kinase.
Jang YJ; Lin CY; Ma S; Erikson RL
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1984-9. PubMed ID: 11854496
[TBL] [Abstract][Full Text] [Related]
18. Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.
Kreis NN; Louwen F; Zimmer B; Yuan J
Oncotarget; 2015 Mar; 6(9):6611-26. PubMed ID: 25483104
[TBL] [Abstract][Full Text] [Related]
19. The Plk3-Cdc25 circuit.
Myer DL; Bahassi el M; Stambrook PJ
Oncogene; 2005 Jan; 24(2):299-305. PubMed ID: 15640846
[TBL] [Abstract][Full Text] [Related]
20. Polo-box domains confer target specificity to the Polo-like kinase family.
van de Weerdt BC; Littler DR; Klompmaker R; Huseinovic A; Fish A; Perrakis A; Medema RH
Biochim Biophys Acta; 2008 Jun; 1783(6):1015-22. PubMed ID: 18359294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
